| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 16320 |
| 1 | ETANERCEPT | 8875 |
| 2 | TIRZEPATIDE | 5540 |
| 3 | TERIPARATIDE | 4517 |
| 4 | EVOLOCUMAB | 4136 |
| 5 | DULAGLUTIDE | 3179 |
| 6 | INTERFERON BETA-1A | 3010 |
| 7 | METFORMIN | 2879 |
| 8 | METHOTREXATE | 2832 |
| 9 | METHOTREXATE SODIUM | 2807 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TESTOSTERONE ENANTHATE | 142 | 0.0865 |
| 1 | ADALIMUMAB-ADBM | 18 | 0.0672 |
| 2 | ERGOCALCIFEROL | 1727 | 0.0581 |
| 3 | GALCANEZUMAB-GNLM | 1666 | 0.0516 |
| 4 | TERIPARATIDE | 4517 | 0.0402 |
| 5 | DULAGLUTIDE | 3179 | 0.0356 |
| 6 | EXENATIDE | 1810 | 0.0346 |
| 7 | RILONACEPT | 39 | 0.0337 |
| 8 | TIRZEPATIDE | 5540 | 0.0306 |
| 9 | ALIROCUMAB | 752 | 0.0292 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 11139 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 9974 |
| 2 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 5540 |
| 3 | PCSK9 Inhibitor [EPC] | 4864 |
| 4 | Parathyroid Hormone Analog [EPC] | 4517 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 4002 |
| 6 | Insulin Analog [EPC] | 3929 |
| 7 | Interferon beta [EPC] | 3276 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 2711 |
| 9 | Corticosteroid [EPC] | 2611 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 149 | 0.2166 |
| 1 | PCSK9 Inhibitor [EPC] | 4864 | 0.1889 |
| 2 | Adrenocorticotropic Hormone [EPC] | 123 | 0.1374 |
| 3 | Provitamin D2 Compound [EPC] | 1727 | 0.0580 |
| 4 | Interleukin-17A Antagonist [EPC] | 1863 | 0.0500 |
| 5 | Parathyroid Hormone Analog [EPC] | 4517 | 0.0402 |
| 6 | Recombinant Human Growth Hormone [EPC] | 659 | 0.0300 |
| 7 | GLP-1 Receptor Agonist [EPC] | 11139 | 0.0248 |
| 8 | Guanylate Cyclase-C Agonist [EPC] | 45 | 0.0217 |
| 9 | Interleukin-23 Antagonist [EPC] | 1996 | 0.0191 |